KPIs & Operating Metrics(New)
Growth Metrics

Amgen (AMGN) Share-based Compensation (2016 - 2026)

Amgen has reported Share-based Compensation over the past 14 years, most recently at $75.0 million for Q1 2026.

  • For Q1 2026, Share-based Compensation fell 11.76% year-over-year to $75.0 million; the TTM value through Mar 2026 reached $484.0 million, down 5.47%, while the annual FY2025 figure was $494.0 million, 6.79% down from the prior year.
  • Share-based Compensation for Q1 2026 was $75.0 million at Amgen, down from $125.0 million in the prior quarter.
  • Over five years, Share-based Compensation peaked at $161.0 million in Q4 2023 and troughed at $47.0 million in Q1 2023.
  • A 4-year average of $117.7 million and a median of $125.0 million in 2025 define the central range for Share-based Compensation.
  • Biggest five-year swings in Share-based Compensation: soared 119.15% in 2024 and later decreased 17.48% in 2025.
  • Year by year, Share-based Compensation stood at $161.0 million in 2023, then decreased by 16.77% to $134.0 million in 2024, then fell by 6.72% to $125.0 million in 2025, then crashed by 40.0% to $75.0 million in 2026.
  • Business Quant data shows Share-based Compensation for AMGN at $75.0 million in Q1 2026, $125.0 million in Q4 2025, and $127.0 million in Q3 2025.